Volume | 8,454,860 |
|
|||||
News | - | ||||||
Day High | 9.015 | Low High |
|||||
Day Low | 8.59 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
8.78 | 8.59 | 9.015 | 8.82 | 8.74 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
19,696 | 8,454,860 | 8.72 | 73,736,619 | - | 4.78 - 10.955 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
20:00:00 | 750,680 | 8.82 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.02B | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.98 | 9.59 | 8.44 | 9.04 | 8,710,045 | -0.16 | -1.78% |
1 Month | 9.52 | 10.955 | 8.44 | 9.61 | 10,396,600 | -0.70 | -7.35% |
3 Months | 9.36 | 10.955 | 7.30 | 9.26 | 8,762,968 | -0.54 | -5.77% |
6 Months | 6.46 | 10.955 | 4.92 | 8.29 | 7,308,136 | 2.36 | 36.53% |
1 Year | 5.13 | 10.955 | 4.78 | 7.73 | 6,033,238 | 3.69 | 71.93% |
3 Years | 39.98 | 44.14 | 4.78 | 10.66 | 2,988,573 | -31.16 | -77.94% |
5 Years | 24.90 | 55.91 | 4.78 | 12.11 | 2,574,000 | -16.08 | -64.58% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |